Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
25 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/25/2952906/0/en/Erasca-to-Present-Preliminary-SEACRAFT-1-Phase-1-Data-for-Naporafenib-Plus-Trametinib-in-RAS-Q61X-Mutant-Solid-Tumors-as-Oral-Presentation-at-36th-EORTC-NCI-AACR-Symposium.html
29 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/29/2937732/0/en/Erasca-to-Present-at-Upcoming-Investor-Conferences-in-September.html
12 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/12/2928728/0/en/Erasca-Reports-Second-Quarter-2024-Business-Updates-and-Financial-Results.html
18 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/18/2900371/0/en/Erasca-Initiates-SEACRAFT-2-Pivotal-Phase-3-Trial-Evaluating-Naporafenib-Plus-Trametinib-in-Patients-with-NRAS-Mutant-Melanoma.html
29 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/29/2889831/0/en/Erasca-to-Present-at-Upcoming-Investor-Conferences-in-June.html
21 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/21/2886024/0/en/Erasca-Announces-Closing-of-Underwritten-Offering-of-Common-Stock-and-Full-Exercise-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?